The Neurosurgery Department at Tel Aviv’s Sourasky Medical Center (also known as Ichilov Hospital) has partnered with Jerusalem-based AI company NeuroBrave in the field of brain-computer interfaces (BCI).
BCI creates a direct link between the electrical activity in the brain and an external device, such as a prosthetic or a computer.
The department’s Functional Neurosurgery Unit, a world leader specializing in the treatment of brain, spinal cord and nervous system disorders, intends to use the new partnership to advance developments in BCI and propel research and implementation of innovative solutions for both complex neurological conditions and patient care.
“For more than a decade, our clinical research team has been at the forefront of speech decoding and brain information research and has accumulated a vast amount of know-how and data,” said Dr. Ido Strauss, head of Sourasky’s Functional Neurosurgery Unit.
“The partnership with NeuroBrave opens exciting possibilities to take the next step in brain-computer interfaces, translate brain activity into speech, and help patients with various brain disorders to communicate,” he said.
“NeuroBrave unique AI and GenAI infrastructure, and the ability to translate, in real-time, neural information into cognitive and emotional insights, combined with the skilled hands and clinical expertise of TASMC Functional Neurosurgery Unit, will enable Israel to join the ‘Brain Chip Race,’ alongside Elon Musk’s Neuralink, and Synchron Inc, having Bill Gates and Jeff Bezos as stakeholders,” said th company’s co-founder and CEO Dror Talisman.
Facebook comments